Clinical trial
Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients…
NCT00237237 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00237237 |
|---|---|
| Title | Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes |
| Official title | Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 Diabetes |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | vildagliptin |
| Enrollment | 588 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2007 |
| First posted | Oct 12, 2005 |
| Last update posted | Feb 7, 2017 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: